This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Erbitux
Brand Name :
Erbitux
Generic Name :
Cetuximab
Partner :
Merck
What is this drug and what is it used for?
Erbitux is used to treat two different types of cancer:
- Metastatic cancer of the large intestine. In these patients, Erbitux is used alone or in combination with other anticancer medicines.
- A certain type of cancer of the head and neck (squamous cell cancer). In these patients, Erbitux is used in combination with radiation therapy or with other anticancer medicines.
How is this drug given?
Dosage and administration
Erbitux is usually infused into a vein (given as a drip) once a week. Your doctor will calculate the correct dose of Erbitux for you because it depends on your body surface area. The first dose (400 mg/m² body surface area) is infused over a period of approximately 2 hours with an infusion rate not faster than 5 mg/min. Each subsequent dose (250 mg/m² body surface area) is infused in approximately 1 hour with an infusion rate not faster than 10 mg/min.
Duration of treatment
Erbitux is usually infused once a week. The duration of treatment may vary depending on your disease as well as from person to person and your doctor will therefore discuss with you how long you will receive Erbitux.